spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 6 Nov 2009
Amarin Appoints John F. Thero as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Nov 2009
EpiCept Corporation Names Bernard Tyrrell as Senior Vice President, Sales and Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Nov 2009
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
Biopharmaceuticals
 HSMN NewsFeed - 5 Nov 2009
Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced Durable Responses in Relapsed Indolent Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Nov 2009
NeurogesX Expands Commercial Operations Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Nov 2009
Metabolex Closes $8.6 Million Financing Round
Biopharmaceuticals Endocrinology Venture Capital
 HSMN NewsFeed - 5 Nov 2009
Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Nov 2009
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Nov 2009
ABRAXANE(R) Receives Orphan Drug Status for the Treatment of Pancreatic Cancer and Stage IIB-IV Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 Nov 2009
Acceleron Pharma Initiates First-in-Human Study of ACE-041, a Novel Angiogenesis Inhibitor, in Patients with Advanced Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Nov 2009
Inspire Completes Patient Enrollment in Three Late-Stage Clinical Trials in Cystic Fibrosis, Dry Eye and Blepharitis
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 4 Nov 2009
Arrowhead Subsidiary Calando Pharmaceuticals Expands Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Nov 2009
NovaRx Corporation Announces FDA Approval of Protocol Amendment to Special Protocol Assessment (SPA) for Phase III Lucanix(R) Study in Non-Small Cell Lung Cancer (NSCLC)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Nov 2009
FDA Approves New Salix Product Exclusively in Catalent's Zydis(R) Fast Dissolve Technology
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 3 Nov 2009
Alnara Pharmaceuticals Announces Appointment of Lee R. Brettman, M.D., FACP, to Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Nov 2009
Johnson & Johnson Announces Restructuring Initiatives for Sustainable Growth
Biopharmaceuticals Devices
 HSMN NewsFeed - 3 Nov 2009
ZEVALIN(R) Receives Positive Reimbursement Ruling Using Average Sales Price (ASP) Methodology
Biopharmaceuticals Oncology Reimbursement
 HSMN NewsFeed - 3 Nov 2009
VIVUS Announces Promotion of Peter Tam to President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Nov 2009
Symphogen Opens US Operations in Princeton, New Jersey
Biopharmaceuticals
 HSMN NewsFeed - 2 Nov 2009
Laureate Pharma Welcomes Three New Members to Business Development Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Nov 2009
Human Genome Sciences and GlaxoSmithKline Announce Positive Results in Second of Two Phase 3 Trials of BENLYSTA in Systemic Lupus Erythematosus
Biopharmaceuticals
 HSMN NewsFeed - 2 Nov 2009
Sosei Signs Definitive Distribution Agreement With ASKA for Commercialisation of SOH-075 (NorLevo(R))
Biopharmaceuticals Distribution
 HSMN NewsFeed - 30 Oct 2009
Watson Names R. Todd Joyce Senior Vice President and Chief Financial Officer; Succeeds Mark W. Durand
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Oct 2009
Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
Biopharmaceuticals
 HSMN NewsFeed - 29 Oct 2009
NeoPharm Names Dr. Aquilur Rahman as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Oct 2009
Genta Announces Top-Line Results of AGENDA Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Oct 2009
Ipsen Announces the Launch of Dysport(R) (abobotulinumtoxinA) in the United States for the Treatment of Cervical Dystonia
Biopharmaceuticals
 HSMN NewsFeed - 29 Oct 2009
Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Oct 2009
Safeguard Scientifics Leads $17.4 Million Series B Financing for Quinnova Pharmaceuticals
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 28 Oct 2009
Morphotek(R), Inc. Announces a Licensing Deal With Centocor Ortho Biotech Inc. for Exclusive Development and Commercialization Rights for a Therapeutic Monoclonal Antibody
Biopharmaceuticals Licensing
 HSMN NewsFeed - 28 Oct 2009
Watson and Barr Settle Lawsuit Over Oxytrol(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 28 Oct 2009
SciClone Announces Corporate Restructuring and Workforce Reduction
Biopharmaceuticals
 HSMN NewsFeed - 28 Oct 2009
Nabriva Therapeutics Raises Euro 15 Million (USD 22 Million)
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Oct 2009
Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Oct 2009
Cephalon Appoints Bob Repella as Senior Vice President of U.S. Pharmaceutical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Oct 2009
Sorrento Therapeutics Announces the Appointment of Martina Molsbergen as Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Oct 2009
Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Oct 2009
New Data Presented From WELCOME Trial Show Positive Impact of CIMZIA(R) (certolizumab pegol) on Hospitalizations and Surgeries in Patients With Prior Infliximab Failure
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 26 Oct 2009
Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Oct 2009
FDA Determines VYVANSE(R) was Properly Granted Five-Year Market Exclusivity
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Oct 2009
Merck and Schering-Plough Receive Approval From European Commission for Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Oct 2009
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Patients With Non-Responsive Thyroid Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Oct 2009
Zogenix and Astellas Announce Data Published Showing the Benefits of SUMAVEL(TM) DosePro(TM) Needle-Free Delivery System
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 21 Oct 2009
CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Oct 2009
Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Oct 2009
NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Oct 2009
Antigenics Announces a Negative Vote From the CHMP on Oncophage(R) Marketing Application in Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 21 Oct 2009
MacuSight(R) Receives Fast Track Designation From FDA for Perceiva(TM) in Treatment of Diabetic Macular Edema
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 21 Oct 2009
Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 21 Oct 2009
FDA Issues Complete Response Letter for CorVue(TM)
Biopharmaceuticals Cardiology Radiology FDA
 HSMN NewsFeed - 21 Oct 2009
Wellstat Therapeutics and sanofi-aventis Enter Agreement on Novel Therapy for Type II Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 20 Oct 2009
New Data Describe Safety of Subcutaneous Administration of ORENCIA(R) (abatacept) For Patients with Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 20 Oct 2009
Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Oct 2009
Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Oct 2009
Human Genome Sciences and GlaxoSmithKline Announce Full Presentation at ACR of Positive Phase 3 Study Results for BENLYSTA in Systemic Lupus Erythematosus
Biopharmaceuticals
 HSMN NewsFeed - 19 Oct 2009
FDA Approves Colcrys(TM) (colchicine, USP) for Prevention of Gout Flares
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Oct 2009
Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Oct 2009
Perrigo Announces Dismissal of Duac(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 19 Oct 2009
Endo Pharmaceuticals Gives Update on Regulatory Status of FORTESTA(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Oct 2009
FDA Approves New Use for Micardis(R) in Cardiovascular Risk Reduction and Twynsta(R) as New Combination Treatment for High Blood Pressure
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 19 Oct 2009
Facet Biotech's Board of Directors Recommends Stockholders Continue to Reject Biogen Idec's Tender Offer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Oct 2009
New SIMPONI(TM) Data Show Long-Term Efficacy in Treatment of Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 19 Oct 2009
New SIMPONI(TM) Data Show Inhibition of Joint Damage in Patients With Rheumatoid Arthritis and Psoriatic Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 19 Oct 2009
Amgen Provides Update on Status of Prolia(TM) (Denosumab) Biologics License Application (BLA) Submitted to the U.S. Food and Drug Administration (FDA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Oct 2009
Aileron Therapeutics Appoints Steven Kafka, Ph.D. as Company's First Chief Financial Officer and Vice President, Finance and Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Oct 2009
Lux Biosciences Completes $50 Million Series B Financing
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 19 Oct 2009
NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Oct 2009
Talecris Biotherapeutics Receives FDA Approval for PROLASTIN(R)-C
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Oct 2009
QLT restructures Visudyne(R) agreement
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 17 Oct 2009
FDA Approves GARDASIL(R) for Use in Boys and Young Men
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Oct 2009
FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Oct 2009
FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Oct 2009
Endocyte Officials Announce Close of $26 Million Equity Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Oct 2009
Cancer Therapeutics Announces Letter of Intent With NanoTherapies, LLC
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 15 Oct 2009
Pfizer Completes Acquisition Of Wyeth
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Oct 2009
Positive Findings from Excellarate(TM) Phase 1/2 Clinical Study Published in Journal of Wound Repair and Regeneration
Devices Biopharmaceuticals Wound Care
 HSMN NewsFeed - 15 Oct 2009
Threshold Pharmaceuticals Licenses Glufosfamide to Eleison Pharmaceuticals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 15 Oct 2009
Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 15 Oct 2009
OXiGENE to Acquire VaxGen in a Stock-for-Stock Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Oct 2009
Pfizer Receives Clearance From The U.S. Federal Trade Commission And The Canadian Competition Bureau For Wyeth Acquisition
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Oct 2009
Timm Medical Technologies and Ferring Pharmaceuticals Enter Exclusive Co-Promotion Agreement for Prosed(R) DS
Biopharmaceuticals Urology
 HSMN NewsFeed - 14 Oct 2009
AcelRx Pharmaceuticals Hires Nigel Ray as Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Oct 2009
XOMA Appoints Susan Kramer, Dr. P.H. Vice President of Project and Alliance Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Oct 2009
Advanced U.S. Clinical Trial Confirms Single-Agent Efficacy of Rexin-G in Metastatic Pancreas Cancer: All Endpoints Achieved
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Oct 2009
Basilea's Toctino(R) receives marketing authorization in Switzerland
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 13 Oct 2009
CalciMedica Appoints Evelyn Graham to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Oct 2009
Seattle Genetics Names Head of Commercial and Announces Management Promotion
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Oct 2009
Amarin Announces Changes to Its Board and Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Oct 2009
Meda Launches Onsolis(TM) (Fentanyl Buccal Soluble Film) for the Treatment of Breakthrough Cancer Pain in Opioid Tolerant Patients
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 13 Oct 2009
Transdel Pharmaceuticals Appoints Dr. Joachim P.H. Schupp as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Oct 2009
AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy
Biopharmaceuticals Regulatory Neurology
 HSMN NewsFeed - 12 Oct 2009
Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
Biopharmaceuticals Licensing
 HSMN NewsFeed - 12 Oct 2009
Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
Biopharmaceuticals Licensing
 HSMN NewsFeed - 12 Oct 2009
CSL Behring Announces FDA Approval of Berinert(R), First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema in U.S.
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Oct 2009
Proteolix, Inc. to be Acquired By Onyx Pharmaceuticals
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 12 Oct 2009
Onyx Pharmaceuticals to Acquire Proteolix, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 9 Oct 2009
Lycera Appoints Key Executives to Drug Development Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Oct 2009
FDA Advisory Committee Recommends Approval of Pfizer's Selzentry for Use in Patients Starting HIV Therapy for the First Time
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 8 Oct 2009
Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
Biopharmaceuticals Generics
 HSMN NewsFeed - 8 Oct 2009
Declaratory Judgment Action Filed by GSK
Biopharmaceuticals Litigation
 HSMN NewsFeed - 8 Oct 2009
Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796, Broad-Spectrum Oral and IV Antibiotic in Phase 3
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Oct 2009
Epizyme Closes $32 Million Series B Financing, Led by New Investor Bay City Capital
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Oct 2009
Amber Salzman Named President and CEO of Cardiokine
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Oct 2009
Baxter Receives European Commission Approval for CELVAPAN H1N1 Pandemic Influenza Vaccine
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Oct 2009
Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today
Biopharmaceuticals
 HSMN NewsFeed - 6 Oct 2009
SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 6 Oct 2009
ABT Molecular Imaging Announces $9 Million Financing
Biopharmaceuticals Radiology Oncology Venture Capital
 HSMN NewsFeed - 6 Oct 2009
SurModics Enters Ophthalmic License and Development Agreement with Roche and Genentech
Biopharmaceuticals Ophthalmology Drug Delivery Licensing
 HSMN NewsFeed - 6 Oct 2009
Transdel Pharmaceuticals Announces Positive Phase 3 Study Results for Lead Topical Pain Drug Ketotransdel(R)
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 5 Oct 2009
GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT(TM)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Oct 2009
FDA Advisory Committee Recommends Approval of PEGINTRON(R) for the Adjuvant Treatment of Stage III Malignant Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Oct 2009
Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 5 Oct 2009
NeuroTherapeutics Pharma Appoints Dr. Corey Goodman to Its Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 5 Oct 2009
Oncothyreon announces appointment of Douglas E. Williams, Ph.D., to board of directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Oct 2009
Baxter Announces the Commercial Launch of HYLENEX at ACEP for Use in Pediatric Rehydration
Biopharmaceuticals
 HSMN NewsFeed - 5 Oct 2009
Impax Laboratories Receives Tentative FDA Approval for Generic FLOMAX(R) 0.4mg Capsules
Biopharmaceuticals Urology Generics FDA
 HSMN NewsFeed - 2 Oct 2009
Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
Biopharmaceuticals Litigation Licensing
 HSMN NewsFeed - 2 Oct 2009
The Medicines Company Announces the Resignation of Its Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2009
Arginetix Closes $10.75 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Oct 2009
Astellas and Theravance Announce Approval of VIBATIV(TM) (telavancin) in Canada for the Treatment of Complicated Skin and Skin Structure Infections
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 30 Sep 2009
Aileron Appoints Industry Veteran Diane Jorkasky, M.D., as Company's Head of Development and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Sep 2009
Mylan Receives FDA Approval for Generic Version of Parkinson's Treatment Sinemet(R)
Biopharmaceuticals Generics Neurology FDA
 HSMN NewsFeed - 30 Sep 2009
Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Sep 2009
Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Sep 2009
Wound Management Technologies Adds Major U.S. Independent Sales Organization
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 29 Sep 2009
Boehringer Ingelheim's Diabetes Pipeline Continues to Advance as the Company Announces Conclusion of Robust Phase III Clinical Program for linagliptin
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 29 Sep 2009
Repros Therapeutics Inc. Provides Update on Proellex
Biopharmaceuticals
 HSMN NewsFeed - 29 Sep 2009
Cell Therapeutics Applies for European Orphan Drug Designation for Pixantrone in Aggressive Non-Hodgkin's Lymphoma (NHL)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 28 Sep 2009
Maxygen Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Sep 2009
Bausch & Lomb Subsidiaries and CROMA will Co-Promote Bromfenac Ophthalmic Solution in Europe
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 28 Sep 2009
Merck & Co., Inc. Obtains Exclusive U.S. Marketing Rights for AFLURIA(R), Seasonal Influenza Vaccine from CSL Biotherapies
Biopharmaceuticals Distribution
 HSMN NewsFeed - 28 Sep 2009
CSL Biotherapies Reaches Agreement with Merck & Co. on Rights to Market and Distribute Afluria(R) in the U.S.
Biopharmaceuticals Distribution
 HSMN NewsFeed - 28 Sep 2009
sanofi-aventis: Multaq(R) (dronedarone) Recommended for Approval in the European Union
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 28 Sep 2009
MSD Receives Positive CHMP Opinion for 'Januvia(R)' and 'Janumet(R)' as Add-On to Insulin in the European Union
Biopharmaceuticals Endocrinology Regulatory
 HSMN NewsFeed - 28 Sep 2009
Johnson & Johnson and Crucell Announce Strategic Collaboration to Develop Innovative Products, Including Therapies for Influenza Prevention and Treatment
Biopharmaceuticals
 HSMN NewsFeed - 28 Sep 2009
Abbott to Acquire Solvay Pharmaceuticals Business
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Sep 2009
Teva Provides Update on Generic Seroquel(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 25 Sep 2009
Quintiles and Allergan Announce Co-Promotion for Sanctura XR(R)
Biopharmaceuticals Urology
 HSMN NewsFeed - 25 Sep 2009
Frances D. Fergusson And John P. Mascotte Elected To Pfizer's Board Of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Sep 2009
Nile Therapeutics Appoints Frank Litvack, M.D., to Board of Directors
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 25 Sep 2009
Allos Therapeutics' FOLOTYN First and Only FDA-Approved Therapy for Relapsed or Refractory Peripheral T-cell Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Sep 2009
Ticagrelor Reduced Cardiovascular Deaths and Heart Attacks in ACS Patients Undergoing Heart Procedures: New Data from PLATO Trial
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 24 Sep 2009
Portola Pharmaceuticals Announces Promotions of Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Sep 2009
Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Sep 2009
Pfizer Launches Phase 3 Clinical Trial With Novel Alk Inhibitor In Non-Small Cell Lung Cancer Patients With Specific Gene Mutation
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Sep 2009
Teva Provides Update on Generic Evista(R) Litigation
Biopharmaceuticals Generics Oncology Litigation
 HSMN NewsFeed - 24 Sep 2009
Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in First-Line Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Sep 2009
Data Presented from Two Phase 3 ERBITUX(R) Studies in First-Line Metastatic Colorectal Cancer Patients at Joint 15th European Cancer Organisation and 34th European Society for Medical Oncology Multidisciplinary Congress
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Sep 2009
BurnsAdler Partners With Three Rivers Pharmaceuticals to Commercialize Infergen(R) in Brazil and Chile
Biopharmaceuticals Licensing
 HSMN NewsFeed - 23 Sep 2009
Janssen-Cilag's STELARA(R) (Black Triangle Drug) (ustekinumab) Approved by NICE for the Treatment of Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 22 Sep 2009
Lilly Announces New U.S. Affiliate Leader
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Sep 2009
Variation Biotechnologies Names Jeff Baxter CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Sep 2009
Micromet Appoints Former Roche Oncology Clinical Leader Jan Fagerberg as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Sep 2009
Denosumab Demonstrates Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Sep 2009
Bayer's Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Sep 2009
Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in Second-Line Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Sep 2009
Perrigo Acquires ANDA for Generic Version Duac(R) Gel From KV Pharmaceutical
Biopharmaceuticals Generics Dermatology Acquisitions
 HSMN NewsFeed - 21 Sep 2009
Merrimack Pharmaceuticals Names Clet Niyikiza, Ph.D. Senior Vice President, Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2009
Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Sep 2009
AZZALURE(R) approved in Spain for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 18 Sep 2009
FDA Grants Priority Review Status to Supplement Containing Long-Term Survival Data for VELCADE(R) (bortezomib) for Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Sep 2009
sanofi-aventis Completes Acquisition of Merck's Interest in Merial
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Sep 2009
Juvaris BioTherapeutics Announces First Close on $25 million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Sep 2009
Seaside Therapeutics Secures $30 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Sep 2009
Phase III Study Showed Patients Lived Longer Without Low-Grade Lymphoma Progressing When Rituxan Was Used First-Line for Maintenance
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Sep 2009
U.S. Food and Drug Administration's Arthritis Advisory Committee Votes Unanimously 12-0 to Recommend Approval of XIAFLEX(TM) for Dupuytren's Contracture
Biopharmaceuticals
 HSMN NewsFeed - 16 Sep 2009
PharmAbcine Closes USD $6 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Sep 2009
Sirion Therapeutics Announces FDA Approval of Zirgan(TM) (Ganciclovir Ophthalmic Gel) 0.15% for Herpetic Keratitis
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 16 Sep 2009
Keryx Biopharmaceuticals Receives Orphan-Drug Designation for KRX-0401 (Perifosine) for the Treatment of Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Sep 2009
AVEO Pharmaceuticals Appoints William J. Slichenmyer, M.D., Sc.M., as Chief Medical Officer and Robert C. Young, M.D., to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Sep 2009
Oculus Innovative Sciences Announces New Partnership Agreement with V&M Industries, Inc. for Microcyn(R)-Based OTC Human Wound Care Products
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 16 Sep 2009
Rib-X Pharmaceuticals, Inc. Appoints Tony Zook of MedImmune to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Sep 2009
Plan B(R) One-Step Emergency Contraception Now Available At U.S. Pharmacies
Biopharmaceuticals
 HSMN NewsFeed - 16 Sep 2009
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 16 Sep 2009
Pervasis Therapeutics Announces $17 Million in Financing and New Board Member
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 15 Sep 2009
Alvine Pharmaceuticals Raises $21.5 Million Series A Extension
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Sep 2009
Wyeth Presents Data from Five-Year Vertebral Fracture Prevention Study with Bazedoxifene
Biopharmaceuticals
 HSMN NewsFeed - 15 Sep 2009
European Union Commission Approves Expanded Use of ISENTRESS(R) (raltegravir), from MSD, in Adult Patients with HIV-1 Infection
Biopharmaceuticals Regulatory HIV/AIDS
 HSMN NewsFeed - 15 Sep 2009
Forest Laboratories UK Ltd Submits Marketing Authorisation Application for the First Dry Powder Inhalation Antibiotic for Cystic Fibrosis Patients
Biopharmaceuticals
 HSMN NewsFeed - 14 Sep 2009
Elan Cures Breach of Tysabri(R) Collaboration Agreement and Amends Terms of Transaction with Johnson & Johnson
Biopharmaceuticals Litigation
 HSMN NewsFeed - 14 Sep 2009
InteKrin Therapeutics Appoints Linda Slanec Higgins, PhD Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Sep 2009
Ironwood Appoints Thomas McCourt As Chief Commercial Officer and Senior Vice President of Marketing and Sales
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Sep 2009
Lilly Names New Business Leaders
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Sep 2009
POZEN Names Elizabeth A. Cermak as Executive Vice President, Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Sep 2009
GENova Biotherapeutics prepares a 510(k) submission to the FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Sep 2009
Schering-Plough Reports Data From SAPHRIS(R) (asenapine) Long-Term Schizophrenia Relapse Prevention Study
Biopharmaceuticals
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!